Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
Clinical trial NCT02820857 · COMPLETED
Trial details
- NCT number
- NCT02820857
- Sponsor
- Hospices Civils de Lyon
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-04
- Primary completion
- 2022-08-08
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.